1 line
5.2 KiB
JSON
1 line
5.2 KiB
JSON
{"abnormal behaviour": 5.44, "adverse drug reaction": 2.78, "affect lability": 2.28, "affective disorder": 26.91, "aggression": 7.8, "agitation": 7.83, "agranulocytosis": 3.66, "akathisia": 110.06, "altered state of consciousness": 2.41, "anosognosia": 48.63, "antipsychotic drug level below therapeutic": 426.93, "antipsychotic drug level increased": 74.57, "anxiety": 2.41, "apathy": 2.83, "ataxia": 2.19, "autonomic nervous system imbalance": 7.14, "behaviour disorder": 6.11, "blood albumin decreased": 4.27, "blood cholesterol increased": 2.8, "blood creatine phosphokinase increased": 6.67, "blood prolactin abnormal": 100.57, "blood prolactin increased": 27.94, "blood thyroid stimulating hormone increased": 3.89, "blood triglycerides increased": 3.47, "blood urea increased": 2.04, "bradykinesia": 10.26, "bruxism": 14.98, "c-reactive protein increased": 2.58, "cardiac arrest": 2.03, "cardio-respiratory arrest": 5.87, "cardiomyopathy": 3.78, "catatonia": 55.37, "clonus": 11.3, "cognitive disorder": 2.15, "cogwheel rigidity": 102.81, "coma": 3.74, "coma scale abnormal": 15.77, "completed suicide": 17.52, "condition aggravated": 2.49, "coordination abnormal": 2.68, "delirium": 4.66, "delusion": 29.02, "delusion of grandeur": 512.89, "depressed level of consciousness": 2.08, "depressed mood": 2.76, "depression": 2.28, "depressive symptom": 5.88, "disinhibition": 167.12, "disorientation": 2.03, "disturbance in social behaviour": 23.52, "drooling": 12.55, "drug abuse": 8.54, "drug dependence": 2.35, "drug ineffective": 3.53, "drug ineffective for unapproved indication": 5.17, "drug interaction": 10.13, "drug level increased": 18.97, "drug reaction with eosinophilia and systemic symptoms": 3.2, "drug resistance": 3.6, "dysarthria": 3.28, "dyskinesia": 10.41, "dyslipidaemia": 14.9, "dystonia": 46.16, "ejection fraction decreased": 2.96, "electrocardiogram qrs complex prolonged": 37.14, "electrocardiogram qt prolonged": 15.16, "emotional disorder": 2.48, "eosinophilia": 3.07, "erectile dysfunction": 2.21, "euphoric mood": 39.49, "extrapyramidal disorder": 105.34, "foetal exposure during pregnancy": 2.77, "galactorrhoea": 17.0, "gambling disorder": 13.51, "gynaecomastia": 7.71, "hallucination": 2.38, "hallucination, auditory": 30.74, "hallucination, visual": 4.8, "head titubation": 25.53, "high density lipoprotein decreased": 18.23, "hypercholesterolaemia": 3.09, "hyperprolactinaemia": 71.7, "hyperreflexia": 21.62, "hypersexuality": 43.05, "hyperthermia": 2.53, "hypertonia": 7.96, "hypomania": 23.53, "hypothermia": 2.42, "incorrect dose administered": 2.49, "increased appetite": 21.28, "intentional overdose": 12.7, "intentional product misuse": 5.34, "intentional self-injury": 15.82, "irritability": 3.62, "left ventricular dysfunction": 10.84, "leukaemia": 9.02, "leukocytosis": 5.83, "leukopenia": 6.24, "lymphocyte count abnormal": 60.95, "lymphocyte count decreased": 9.73, "mania": 17.25, "maternal exposure during pregnancy": 2.05, "mental disorder": 3.88, "mental impairment": 5.15, "metabolic disorder": 8.37, "metabolic syndrome": 18.92, "mitral valve incompetence": 6.01, "mood altered": 3.18, "mucosal inflammation": 2.52, "muscle rigidity": 18.11, "mutism": 23.81, "mydriasis": 4.36, "myoclonus": 4.61, "nandrug interaction": 3767.49, "neuroleptic malignant syndrome": 50.01, "neutropenia": 2.34, "neutrophil count decreased": 2.84, "neutrophil count increased": 21.89, "obesity": 13.42, "obsessive-compulsive disorder": 86.69, "oculogyric crisis": 52.53, "orthostatic hypotension": 8.3, "overdose": 7.36, "paradoxical drug reaction": 16.57, "paranoia": 10.38, "parkinson's disease": 2.14, "parkinsonism": 52.11, "peritonitis": 4.04, "persecutory delusion": 27.86, "personality change": 4.2, "pneumonia aspiration": 2.29, "premature baby": 4.19, "premature delivery": 6.14, "prescribed overdose": 6.05, "priapism": 10.42, "product substitution issue": 5.39, "product use in unapproved indication": 5.71, "product use issue": 2.11, "psychiatric symptom": 7.83, "psychomotor hyperactivity": 11.6, "psychomotor retardation": 30.47, "psychotic disorder": 24.24, "psychotic symptom": 53.41, "pulmonary valve incompetence": 83.36, "red cell distribution width increased": 11.33, "respiratory arrest": 4.03, "respiratory depression": 5.19, "restless legs syndrome": 2.74, "restlessness": 4.99, "rhabdomyolysis": 3.63, "rhinalgia": 24.82, "salivary hypersecretion": 25.37, "schizoaffective disorder": 292.61, "schizophrenia": 70.35, "sedation": 31.22, "sedation complication": 76.37, "self-destructive behaviour": 10.44, "serotonin syndrome": 26.5, "sexual dysfunction": 27.47, "sinus tachycardia": 9.8, "social avoidant behaviour": 29.49, "somnolence": 2.55, "speech disorder": 2.07, "suicidal ideation": 4.9, "suicide attempt": 14.36, "suspected suicide": 45.26, "tardive dyskinesia": 60.63, "therapeutic product effect incomplete": 7.56, "therapeutic product effect variable": 119.75, "therapeutic response decreased": 3.01, "thinking abnormal": 6.47, "torticollis": 8.34, "toxicity to various agents": 13.99, "treatment noncompliance": 15.32, "tremor": 2.77, "tricuspid valve incompetence": 7.04, "trismus": 6.79, "troponin increased": 4.04, "type 2 diabetes mellitus": 2.64, "unresponsive to stimuli": 2.3, "urinary incontinence": 3.05, "urinary retention": 2.63, "weight increased": 8.98, "withdrawal syndrome": 4.26} |